Prednisolone mediated suppression of HIV-1 viral load strongly correlates with C-C chemokine CCL2: In vivo and in vitro findings

被引:12
作者
Ansari, Abdul Wahid [1 ]
Schmidt, Reinhold E. [1 ]
Heiken, Hans [1 ]
机构
[1] Hannover Med Sch, Dept Clin Immunol, D-30625 Hannover, Germany
关键词
HIV-1; CCL2; viremia; prednisolone; anti-inflammatory;
D O I
10.1016/j.clim.2007.07.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CCL2 (MCP-1) is a proinflammatory chemokine induced in HIV-1 infection. We have previously demonstrated a significant correlation of CCL2 gene expression with HIV-1 viremia. In this study we investigated the effect of prednisotone on CCL2 gene expression and viral load in an HIV-1-infected patient receiving high-dose prednisotone for severe uveitis. We observed a > 1 log reduction of HIV-1 viral load, associated with more than hundred fold reduction of CCL2 expression at day 3 of prednisolone treatment. In vitro HIV-1 infection of PBMC demonstrated reduced HIV-1 replication in the presence of prednisotone. Flow cytometric analysis revealed 50% reduction of LTR driven GFP activity by prednisolone in GHOST cells. These findings indicate that prednisolone suppresses both HIV-1 viral load and CCL2 mRNA expression, an association which might be exploited for future anti-inflammatory therapeutic strategies in HIV-1 infection. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 4
页数:4
相关论文
共 21 条
[1]   Long-term clinical, immunologic and virologic impact of glucocorticoids on the chronic phase of HIV infection [J].
Andrieu, Jean-Marie ;
Lu, Wei .
BMC MEDICINE, 2004, 2 (1)
[2]   Host chemokine (C-C motif) ligand-2 (CCL2) is differentially regulated in HIV type 1 (HIV-1)-infected individuals [J].
Ansari, Abdul Wahid ;
Bhatnagar, Nupur ;
Dittrich-Breiholz, Oliver ;
Kracht, Michael ;
Schmidt, Reinhold E. ;
Heiken, Hans .
INTERNATIONAL IMMUNOLOGY, 2006, 18 (10) :1443-1451
[3]   SERUM LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) AND SOLUBLE TNF RECEPTORS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - CORRELATIONS TO CLINICAL, IMMUNOLOGICAL, AND VIROLOGICAL PARAMETERS [J].
AUKRUST, P ;
LIABAKK, NB ;
MULLER, F ;
LIEN, E ;
ESPEVIK, T ;
FROLAND, SS .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (02) :420-424
[4]   IMMUNOSUPPRESSION BY GLUCOCORTICOIDS - INHIBITION OF NF-KAPPA-B ACTIVITY THROUGH INDUCTION OF I-KAPPA-B SYNTHESIS [J].
AUPHAN, N ;
DIDONATO, JA ;
ROSETTE, C ;
HELMBERG, A ;
KARIN, M .
SCIENCE, 1995, 270 (5234) :286-290
[5]   MONOCYTE CHEMOATTRACTANT PROTEIN-1 ACTS AS A T-LYMPHOCYTE CHEMOATTRACTANT [J].
CARR, MW ;
ROTH, SJ ;
LUTHER, E ;
ROSE, SS ;
SPRINGER, TA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :3652-3656
[6]   T cell dynamics in HIV-1 infection [J].
Douek, DC ;
Picker, LJ ;
Koup, RA .
ANNUAL REVIEW OF IMMUNOLOGY, 2003, 21 :265-304
[7]   Differential regulation of proinflammatory and hematopoietic cytokines in human macrophages after infection with human immunodeficiency virus [J].
Esser, R ;
Glienke, W ;
vonBriesen, H ;
RubsamenWaigmann, H ;
Andreesen, R .
BLOOD, 1996, 88 (09) :3474-3481
[8]   Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1 [J].
Gu, L ;
Tseng, S ;
Horner, RM ;
Tam, C ;
Loda, M ;
Rollins, BJ .
NATURE, 2000, 404 (6776) :407-411
[9]  
HERBEIN G, 1994, CLIN EXP IMMUNOL, V95, P442, DOI 10.1111/j.1365-2249.1994.tb07016.x
[10]   Glucocorticoids suppress human immunodeficiency virus type-1 long terminal repeat activity in a cell type-specific, glucocorticoid receptor-mediated fashion: direct protective effects at variance with clinical phenomenology [J].
Kino, T ;
Kopp, JB ;
Chrousos, GP .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2000, 75 (4-5) :283-290